A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2002
12/18/2002	EP1265859A2 Amidino compounds useful as nitric oxide synthase inhibitors
12/18/2002	EP1265857A1 Sulfonamide derivatives
12/18/2002	EP1265853A1 Carboxylic acid derivatives as ip antagonists
12/18/2002	EP1265840A2 Novel amphipathic aldehydes and their use as adjuvants and immunoeffectors
12/18/2002	EP1265839A1 Compounds active at the glucocorticoid receptor
12/18/2002	EP1265627A2 Methods and compositions for inhibiting angiogenesis
12/18/2002	EP1265617A2 Novel topical oestroprogestational compositions with systemic effect
12/18/2002	EP1265616A2 Hormone replacement therapy using a combination of conjugated estrogens and medroxyprogesterone acetate
12/18/2002	EP1265609A1 Methods for treating sexual dysfunction with apomorphine at specified plasma concentration levels
12/18/2002	EP1265603A2 Il-8 receptor antagonists
12/18/2002	EP1079833A4 Cocaine receptor binding ligands
12/18/2002	EP0973801B1 GnRH ANTAGONISTS
12/18/2002	EP0891344B1 Alpha-1 adrenergic receptor antagonists
12/18/2002	EP0873309B1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands
12/18/2002	EP0836506B1 Transdermal patch for administering 17-deacetyl norgestimate alone or in combination with an estrogen
12/18/2002	EP0760668B1 Use of magnesium-based products for the treatment or prophylaxis of neoplastic and autoimmune diseases
12/18/2002	CN1385207A Desheng pellet
12/18/2002	CN1385202A Medicine for treating mastosis and preparation process thereof
12/18/2002	CN1385160A Medicine for treating pelvia inflammation
12/17/2002	US6495687 Adenosine receptors are involved in a vast number of peripheral and central regulatory mechanisms such as, for example, vasodilation, cardiac depression, inhibition of lipolysis, inhibition of insulin release and potentiation
12/17/2002	US6495607 Benzocycloheptenes, process for their production, pharmaceutical preparations that contain the latter as well as their use for the production of pharmaceutical agents
12/17/2002	US6495582 Erk (extracellular signal regulated kinase) inhibitors for treatment of cancer, inflammatory disorders, restenosis, and cardiovascular disease
12/17/2002	US6495571 Administering to the mammal an effective cancer treatment amount of the compound 3,5-dichloro-4,6-diethoxy-2-(trichloromethyl)pyridine or and acid addition salt to treat the cancer
12/17/2002	US6495564 Such as 3-(6-((4-chloro-phenyl)-hydroxy-(3-methyl-3h-imidazol-4-yl)-methyl)-1-methyl-2-oxo-1,2-dihydro-quinolin-4-yl)-benzaldehyde o-methyl-oxime; inhibiting abnormal cell growth
12/17/2002	US6495559 For therapy of obesity
12/17/2002	US6495557 Condensed thienopyrimidines with phosphodiesterase-v inhibiting action
12/17/2002	US6495555 Tricyclic Δ-3-piperidines as α2-antagonists
12/17/2002	US6495554 Phosphodiesterase v inhibitors, treating cardiovascular disorders, and therapy of erectile dysfunction.
12/17/2002	US6495552 Treatment or prevention of the diseases and conditions which respond to treatment by retinoids and or which in healthy mammals, including humans, are controlled by natural retinoic acid.
12/17/2002	US6495544 Homoiminopiperidinyl hexanoic acid inhibitors of inducible nitric oxide synthase
12/17/2002	US6495543 Treating or preventing melatoninergic disorders
12/17/2002	US6495516 Method for killing gram-negative bacteria with biologically active peptides from functional domains of bacterial/permeability-increasing protein
12/17/2002	US6495330 Determining the level of p-type inositol phosphoglycans in a biological sample obtained from the patient, wherein said p-type ipgs are capable of activating pyruvate dehydrogenase phosphatase, by immunoassay
12/17/2002	US6495154 On demand administration of clomipramine and salts thereof to treat premature ejaculation
12/17/2002	CA2203389C Bicyclic heterocyclic compounds for the treatment of impotence
12/17/2002	CA2061675C Quinoline-containing ketoacids as leukotriene antagonists
12/14/2002	CA2390686A1 Cofactor-based screening method for nuclear receptor modulators and related modulators
12/12/2002	WO2002099438A2 Modulation of steroid hormone uptake
12/12/2002	WO2002099115A2 Nucleic acid-associated proteins
12/12/2002	WO2002098885A1 Modified psma ligands and uses related thereto
12/12/2002	WO2002098877A1 Pyrazino 1',2':1,6 pyrido 3,4-b indole1,4-dione derivatives
12/12/2002	WO2002098875A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	WO2002098863A1 Fused imidazole derivative
12/12/2002	WO2002098852A2 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	WO2002098428A1 Tetracyclic compounds as pde5-inhibitors
12/12/2002	WO2002098391A2 Process for preparing granular compositions
12/12/2002	WO2002098363A2 NON-PEPTIDE GnRH AGENTS, PHARMACEUTICAL COMPOSITIONS AND METHODS FOR THEIR USES, AND PROCESSES FOR PREPARING THEM
12/12/2002	WO2002076977A3 Rho-kinase inhibitors
12/12/2002	WO2002076976A3 Rho-kinase inhibitors
12/12/2002	WO2002074327A3 Compositions and methods for treating gonadotrophin related illnesses
12/12/2002	WO2002064591A3 Carboline derivatives
12/12/2002	WO2002064543A3 Novel succinate salt of o-desmethyl-venlafaxine
12/12/2002	WO2002056869A3 Method for treating sexual disorders
12/12/2002	WO2002032898A3 Novel anticholinergics, method for the production thereof and use thereof as medicaments
12/12/2002	WO2001054731A3 Ligand conjugates and methods for preparing same
12/12/2002	US20020188143 Steroid compounds, use of these compounds for the preparation of meiosis-regulating medicaments and method for the preparation of these compounds
12/12/2002	US20020188142 17-Side chain alkynyl-and 20-oxopregna-derivatives of vitamin D, methods for their production and pharmaceutical compositions thereof
12/12/2002	US20020188124 Novel spiro compounds
12/12/2002	US20020188029 Methods of treating or preventing weight gain, obesity, and related disorders
12/12/2002	US20020188018 3-indolyl-4-phenyl-1H-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/12/2002	US20020188016 Heterocycle derivatives and methods of use
12/12/2002	US20020188000 Imidazo-pyridine derivatives as ligands for gaba receptors
12/12/2002	US20020187973 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187970 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187969 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187968 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-DIOL
12/12/2002	US20020187967 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187966 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187965 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187964 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187963 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187962 Pharmaceutical compositions and uses for androst-5-ene-3beta, 17beta-diol
12/12/2002	US20020187931 Modulating cell survival by modulating huntingtin function
12/12/2002	US20020187523 Extracellular signaling molecules
12/12/2002	US20020187499 Kit for use in monitoring and treatment of endometriosis
12/12/2002	CA2449843A1 Non-peptide gnrh agents, pharmaceutical compositions and methods for their use, and processes for preparing them
12/12/2002	CA2449771A1 Novel benzothienyl or indole derivatives, and use thereof as inhibitors of prenyl transferase proteins
12/12/2002	CA2448606A1 Nucleic acid-associated proteins
12/12/2002	CA2447935A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
12/12/2002	CA2445460A1 Carboline derivatives as pde-5 inhibitors
12/12/2002	CA2436408A1 Modified psma ligands and uses related thereto
12/11/2002	EP1263959A1 Antibodies to human cd154
12/11/2002	EP1263958A2 Nusap, a gene encoding a tissue-specific nuclear protein, useful as a diagnostic tool and therapeutic agent
12/11/2002	EP1263803A1 Embolic compositions
12/11/2002	EP1263786A2 Methods and compositions for immunoregulation
12/11/2002	EP1263780A2 Liv-1 related protein, polynulceotides encoding the same and use thereof for treatment of cancer
12/11/2002	EP1263767A2 Beta netrin and uses thereof
12/11/2002	EP1263733A2 Derivatives of quinoline as alpha-2 antagonists
12/11/2002	EP1263732A1 Corticotropin releasing factor antagonists
12/11/2002	EP1263730A1 Amine derivatives for the treatment of apoptosis
12/11/2002	EP1263728A2 Pde iv inhibiting amides, compositions and pharmaceutical use
12/11/2002	EP1263722A1 Pharmaceutical compositions containing azetidine derivatives, novel azetidine derivatives and preparation thereof
12/11/2002	EP1263715A1 Novel phenylheteroalkylamine derivatives
12/11/2002	EP1263467A1 Improved paste formulations
12/11/2002	EP1263428A2 Free radical scavengers for the treatment of premature birth
12/11/2002	EP1263427A1 Il-8 receptor antagonists
12/11/2002	EP1163258B1 22r-hydroxycholesta-8,14-diene derivatives for the inhibition of meiosis
12/11/2002	EP0793498B1 Bicyclic heterocyclic compounds for the treatment of impotence
12/11/2002	EP0750909B1 The use of amino hydrogenated quinazoline compounds and derivatives thereof for abstaining from drug dependence
12/11/2002	EP0723447B1 Use of (2-imidazolin-2-ylamino) quinoxaline derivatives

1 ... 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 ... 557